{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:07:42Z","timestamp":1778832462811,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T00:00:00Z","timestamp":1650153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["137689\/2020-9"],"award-info":[{"award-number":["137689\/2020-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["122513\/20215"],"award-info":[{"award-number":["122513\/20215"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jiph.2022.04.008","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T19:54:35Z","timestamp":1650916475000},"page":"638-642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccine in an older patient: Minireview and a case report"],"prefix":"10.1016","volume":"15","author":[{"given":"Paulo Queiroz","family":"Luciano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renan","family":"Binatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Rodrigues","family":"Sodr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9rgio Roberto","family":"Zajac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Augusto Lima","family":"Marson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoela Marques","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2022.04.008_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)01238-1","article-title":"Vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban","volume":"397","author":"Guetl","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2022.04.008_bib2","article-title":"Renal Vein Thrombosis and pulmonary embolism secondary to vaccine-induced thrombotic thrombocytopenia (VITT)","volume":"8","author":"Cliff-patel","year":"2021","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.jiph.2022.04.008_bib3","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/jth.15346","article-title":"Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)","volume":"19","author":"Thaler","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jiph.2022.04.008_bib4","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1097\/TP.0000000000003847","article-title":"Transplantation outcome in recipients engrafted with organs recovered from the first french deceased donor with a SARS-COV-2 vaccine-induced thrombotic thrombocytopenia","volume":"105","author":"Jamme","year":"2021","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.jiph.2022.04.008_bib5","article-title":"Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death following the chadox1 ncov-19 vaccine","volume":"30","author":"Aladdin","year":"2021","journal-title":"J Stroke Cereb Dis"},{"key":"10.1016\/j.jiph.2022.04.008_bib6","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/bloodadvances.2021004904","article-title":"A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2","volume":"5","author":"S\u00f8rensen","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jiph.2022.04.008_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-243931","article-title":"ChAdOx1 nCOV-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis (CVST)","volume":"14","author":"Suresh","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jiph.2022.04.008_bib8","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/eurheartj\/ehab237","article-title":"COVID-19 vaccine induced prothrombotic immune thrombocytopenia","volume":"42","author":"Xie","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jiph.2022.04.008_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-243894","article-title":"Thrombosis and thrombocytopaenia after ChAdOx1 nCoV-19 vaccination: a single UK centre experience","volume":"14","author":"Bano","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jiph.2022.04.008_bib10","article-title":"Deterioration of vaccine\u2010induced immune thrombotic thrombocytopenia treated by heparin and platelet transfusion: Insight from functional cytometry and serotonin release assay","volume":"5","author":"B\u00e9rezn\u00e9","year":"2021","journal-title":"Res Pr Thromb Haemost"},{"issue":"385","key":"10.1016\/j.jiph.2022.04.008_bib11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJMc2109465","article-title":"Therapeutic plasma exchange in vaccine-induced immune thrombotic thrombocytopenia","volume":"26","author":"Patriquin","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2022.04.008_bib12","doi-asserted-by":"crossref","first-page":"e870","DOI":"10.1097\/CCM.0000000000005105","article-title":"Using nonheparin anticoagulant to treat a near-fatal case with multiple venous thrombotic lesions during ChAdOx1 nCoV-19 vaccination-related vaccine-induced immune thrombotic thrombocytopenia","volume":"49","author":"Bersinger","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiph.2022.04.008_bib13","article-title":"COVID-19 vaccine-induced thrombotic thrombocytopenia: a case series","volume":"13","author":"Alalwan","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jiph.2022.04.008_bib14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.25259\/SNI_689_2021","article-title":"A rare case of vaccine-induced immune thrombosis and thrombocytopenia and approach to management","volume":"12","author":"Kotal","year":"2021","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.jiph.2022.04.008_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejim.2021.06.025","article-title":"Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT)","volume":"91","author":"Varona","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jiph.2022.04.008_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-244223","article-title":"A rare case of COVID-19 vaccine-induced thrombotic thrombocytopaenia (VITT) involving the veno-splanchnic and pulmonary arterial circulation, from a UK district general hospital","volume":"14","author":"Asmat","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jiph.2022.04.008_bib17","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa2107051","article-title":"Adjunct immune globulin for vaccine-induced thrombotic thrombocytopenia","volume":"385","author":"Bourguignon","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2022.04.008_bib18","article-title":"Vaccine\u2010induced immune thrombotic thrombocytopenia presenting with normal platelet count","volume":"5","author":"Page","year":"2021","journal-title":"Res Pr Thromb Haemost"},{"key":"10.1016\/j.jiph.2022.04.008_bib19","article-title":"Vaccine\u2010induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine\u2013A case report","volume":"5","author":"Al Rawahi","year":"2021","journal-title":"Res Pr Thromb Haemost"},{"key":"10.1016\/j.jiph.2022.04.008_bib20","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1038\/s41467-021-25010-x","article-title":"Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia","volume":"12","author":"De Michele","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiph.2022.04.008_bib21","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3390\/vaccines9111344","article-title":"Complicated longterm vaccine induced thrombotic immune thrombocytopenia - case report","volume":"9","author":"G\u00fcnther","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jiph.2022.04.008_bib22","article-title":"Treatment of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia related acute ischemic stroke","volume":"30","author":"Kenda","year":"2021","journal-title":"J Stroke Cereb Dis"},{"key":"10.1016\/j.jiph.2022.04.008_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/bjh.17613","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentations","volume":"195","author":"Lavin","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jiph.2022.04.008_bib24","first-page":"1","article-title":"Successful treatment of vaccine-induced immune thrombotic thrombocytopenia in a 26-year-old female patient","author":"Kemper","year":"2021","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jiph.2022.04.008_bib25","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1136\/jnnp-2021-326984","article-title":"Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"92","author":"Al-Mayhani","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jiph.2022.04.008_bib26","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1007\/s00415-021-10599-2","volume":"268","author":"Graf","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.jiph.2022.04.008_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s13256-021-03083-y","article-title":"Diffuse prothrombotic syndrome after ChAdOx1 nCoV-19 vaccine administration: a case report","volume":"15","author":"Ceschia","year":"2021","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jiph.2022.04.008_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcrc.2021.05.021","article-title":"Successful treatment of acute spleno-porto-mesenteric vein thrombosis after ChAdOx1 nCoV-19 vaccine. A case report","volume":"65","author":"Umbrello","year":"2021","journal-title":"J Crit Care"},{"key":"10.1016\/j.jiph.2022.04.008_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-245440","article-title":"Haematuria, a widespread petechial rash, and headaches following the Oxford AstraZeneca ChAdOx1 nCoV-19 Vaccination","volume":"14","author":"Waraich","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jiph.2022.04.008_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-246200","article-title":"Munir. Cerebral venous sinus thrombosis secondary to ChAdOx-1 nCov-19 vaccine","volume":"14","author":"Atta","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jiph.2022.04.008_bib31","article-title":"Post COVID-19 vaccine related cerebral venous sinus thrombosis and thrombocytopenia","volume":"14","author":"Butler-Manuel","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jiph.2022.04.008_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-245445","article-title":"Cerebral arterial and venous thrombosis due to COVID-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"15","author":"Pang","year":"2022","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jiph.2022.04.008_bib33","doi-asserted-by":"crossref","first-page":"427.e3","DOI":"10.1016\/j.ajem.2021.07.011","article-title":"Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination","volume":"51","author":"Guan","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jiph.2022.04.008_bib34","doi-asserted-by":"crossref","first-page":"441.e3","DOI":"10.1016\/j.ajem.2021.05.001","article-title":"Thrombotic thrombocytopenic purpura after Ad26.COV2-S vaccination","volume":"49","author":"Yocum","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jiph.2022.04.008_bib35","article-title":"Vaccine-induced immune thrombotic thrombocytopenia with concurrent arterial and venous thrombi following Ad26.COV2.S vaccination","volume":"30","author":"Charidimou","year":"2021","journal-title":"J Stroke Cereb Dis"},{"key":"10.1016\/j.jiph.2022.04.008_bib36","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.annemergmed.2021.04.035","article-title":"Early outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after Ad26.COV2.S vaccination","volume":"78","author":"Clark","year":"2021","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jiph.2022.04.008_bib37","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1055\/a-1499-0119","article-title":"SARS-CoV-2 vaccine and thrombosis: an expert consensus on vaccine-induced immune thrombotic thrombocytopenia","volume":"121","author":"Elalamy","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jiph.2022.04.008_bib38","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2022.04.008_bib39","unstructured":"British Society for Haemotology. Guidance produced from the Expert Haematology Panel (EHP) focused on Covid-19 Vaccine induced Thrombosis and Thrombocytopenia (VITT), \u3008https:\/\/b-s-h.org.uk\/media\/19530\/guidance-version-13-on-mngmt-of-thrombosis-with-thrombocytopenia-occurring-after-c-19-vaccine_20210407.pdf\u3009."},{"key":"10.1016\/j.jiph.2022.04.008_bib40","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1161\/STROKEAHA.121.035613","article-title":"Cerebral vein thrombosis with vaccine-induced immune thrombotic thrombocytopenia","volume":"52","author":"Siegler","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jiph.2022.04.008_bib41","unstructured":"Coronavirus vaccine - weekly summary of Yellow Card reporting. [published update online May 5, 2021]. \u3008https:\/\/www.gov.uk\/government\/publications\/coronavirus-covid-19-vaccine-adverse-reactions\/coronavirus-vaccine-summary-of-yellow-card-reporting\u3009. Accessed May 16, 2021."},{"key":"10.1016\/j.jiph.2022.04.008_bib42","doi-asserted-by":"crossref","first-page":"680","DOI":"10.15585\/mmwr.mm7018e2","article-title":"Safety monitoring of the Janssen (Johnson & Johnson) COVID-19 vaccine - United States, March-April 2021","volume":"70","author":"Shay","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jiph.2022.04.008_bib43","doi-asserted-by":"crossref","first-page":"E913","DOI":"10.1503\/cmaj.210882","article-title":"Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia","volume":"193","author":"Sholzberg","year":"2021","journal-title":"CMAJ"},{"key":"10.1016\/j.jiph.2022.04.008_bib44","unstructured":"Barnes G.D., Cuker A., Piazza G., Siegal D. Vaccine-induced thrombotic thrombocytopenia (VITT) and COVID-19 vaccines: what cardiovascular clinicians need to know. Cardiology Magazine. 2021 [published online November 2021]. https:\/\/www.pshp.org\/news\/588515\/COVID-19-Vaccine-Induced-Thrombotic-Thrombocytopenia-VITT.htm. Accessed 1 December, 2022."},{"key":"10.1016\/j.jiph.2022.04.008_bib45","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine\u2013induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2022.04.008_bib46","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2022.04.008_bib47","doi-asserted-by":"crossref","first-page":"2100956","DOI":"10.1183\/13993003.00956-2021","article-title":"Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase","volume":"58","author":"Smadja","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiph.2022.04.008_bib48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.thromres.2021.05.010","article-title":"Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination","volume":"203","author":"Douxfils","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jiph.2022.04.008_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/ejh.13665","article-title":"COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome","volume":"107","author":"Franchini","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jiph.2022.04.008_bib50","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1002\/jgm.553","article-title":"Adenovirus endocytosis","volume":"6","author":"Meier","year":"2004","journal-title":"J Gene Med"},{"key":"10.1016\/j.jiph.2022.04.008_bib51","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3389\/fimmu.2014.00649","article-title":"Platelets and infection - an emerging role of platelets in viral infection","volume":"5","author":"Assinger","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiph.2022.04.008_bib52","unstructured":"Chiang KC, Gupta C. Mechanism of thrombosis with AstraZeneca and J & J vaccines: Expert Opinion by Kate Chander Chiang & Ajay Gupta, MD. [published online 2021]. \u3008https:\/\/pharmaceuticalintelligence.com\/2021\/04\/14\/mechanism-of-thrombosis-with-astrazeneca-and-j-j-vaccines-expert-opinion-by-kate-chander-chiang-ajay-gupta-md\/\u3009. Accessed\u00a08 February, 2022."},{"key":"10.1016\/j.jiph.2022.04.008_bib53","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2008-04-153288","article-title":"Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion","volume":"112","author":"Xiao","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jiph.2022.04.008_bib54","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood.V97.10.3300","article-title":"Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia","volume":"97","author":"Pouplard","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jiph.2022.04.008_bib55","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1182\/blood-2011-06-359430","article-title":"PF4\/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcgammaRI","volume":"119","author":"Kasthuri","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jiph.2022.04.008_bib56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1172\/JCI116987","article-title":"Antibodies from patients with heparininduced thrombocytopenia\/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells","volume":"93","author":"Visentin","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jiph.2022.04.008_bib57","doi-asserted-by":"crossref","unstructured":"Greinacher ASK, Wesche J., Handtke S., Palankar R., Aurich K., Lalk M., et al. Towards understanding ChAdOx1 nCov-19 vaccine induced immune thrombotic thrombocytopenia (VITT). [published online 2021]. \u3008https:\/\/pesquisa.bvsalud.org\/global-literature-on-novel-coronavirus-2019-ncov\/resource\/pt\/covidwho-1509159\u3009. Accessed February 8, 2022.","DOI":"10.1182\/blood.2021013231"},{"key":"10.1016\/j.jiph.2022.04.008_bib58","unstructured":"Kowarz EKL, Reis J., Bracharz S., Kochanek S., Marschalek R. Vaccine-Induced Covid-19 Mimicry Syndrome: Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines. Research Square 2021. [published online May 2021]. chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/viewer.html?pdfurl=https%3A%2F%2Fassets.researchsquare.com%2Ffiles%2Frs-558954%2Fv1%2F4727cc99\u20133f39\u20134d1c-a3c8\u201374e1266dedf9.pdf%3Fc%3D1644930056&clen=806025&chunk=true. Accessed Dezember 1, 2022."},{"key":"10.1016\/j.jiph.2022.04.008_bib59","doi-asserted-by":"crossref","unstructured":"Comparing the COVID-19 Vaccines: How Are They Different? [published online January 2022]. \u3008https:\/\/www.yalemedicine.org\/news\/covid-19-vaccine-comparison\u3009. Accessed 8 February, 2022.","DOI":"10.12816\/0059056"},{"key":"10.1016\/j.jiph.2022.04.008_bib60","unstructured":"Ministry of Health (BR). Special Epidemiological Bulletin - New Coronavirus Disease \u2013 COVID-19 [Internet]. Bras\u00edlia: Ministry of Health; 2021 [in 2021 December 7]. Available in (Portuguese): \u3008https:\/\/www.gov.br\/saude\/pt-br\/media\/pdf\/2021\/novembro\/26\/boletim_epidemiologico_covid_90_26nov21_eapv3b.pdf\u3009."},{"key":"10.1016\/j.jiph.2022.04.008_bib61","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(21)01693-7","article-title":"Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis","volume":"398","author":"Bhuyan","year":"2021","journal-title":"Lancet"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034122000922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034122000922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:13:48Z","timestamp":1778829228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034122000922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1876034122000922"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2022.04.008","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccine in an older patient: Minireview and a case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2022.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}